Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06991049 · ClinicalTrials.gov registry record · NA

Early Versus Late Endoscopic Stenting for Refractory Benign Esophageal Strictures

A NA study of Refractory Benign Esophageal Strictures, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06991049: Recruiting NA study of Refractory Benign Esophageal Strictures, sponsored by Medical College of Wisconsin.

NCT06991049 is a NA study of Refractory Benign Esophageal Strictures that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06991049, a NA study of Refractory Benign Esophageal Strictures, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This project is being done to compare two current treatment clinical options for management of RBES: 1) Frequent dilations followed by temporary esophageal stent placement if dilations fail, or 2) Early stent placement followed by dilations

Primary Outcome

The duration required to achieve and maintain an esophageal diameter of ≥14 mm using the two techniques.

Interventions

  • DEVICE Fully covered self-expandable metal esophageal stent

Study Locations (1)

Wisconsin

  • Froedtert Hospital - Milwaukee

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-10-14
Est. Completion 2027-07
Phase NA
Medical College of Wisconsin

447 total trials

What NCT06991049 shows while recruiting

NCT06991049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Refractory Benign Esophageal Strictures appearing as the primary indexed condition, and to 1 intervention - of which Fully covered self-expandable metal esophageal stent is the first listed.

NCT06991049 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06991049 about?

NCT06991049 is a clinical study titled "Early Versus Late Endoscopic Stenting for Refractory Benign Esophageal Strictures". This project is being done to compare two current treatment clinical options for management of RBES: 1) Frequent dilations followed by temporary esophageal stent placement if dilations fail, or 2) Early stent placement followed by dilations

What is the current status of trial NCT06991049?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-10-14. Estimated completion is 2027-07.

What conditions does trial NCT06991049 study?

This clinical trial studies the following conditions: Refractory Benign Esophageal Strictures.

What interventions are being tested in trial NCT06991049?

The interventions under investigation include: Fully covered self-expandable metal esophageal stent (DEVICE).

Who is sponsoring clinical trial NCT06991049?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06991049 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT06991049's enrollment target sits among peer trials

20 1769th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06991049, the US trial registry maintained by the National Library of Medicine. NCT06991049 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.